» Authors » Hany E Marei

Hany E Marei

Explore the profile of Hany E Marei including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 808
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Marei H, Bedair K, Hasan A, Al-Mansoori L, Caratelli S, Sconocchia G, et al.
Cancer Cell Int . 2025 Jan; 25(1):3. PMID: 39755633
Breast cancer will overtake all other cancers in terms of diagnoses in 2024. Breast cancer counts highest among women in terms of cancer incidence and death rates. Innovative treatment approaches...
2.
Marei H, Aslam Khan M, Hasan A
Cell Mol Biol Lett . 2023 Nov; 28(1):98. PMID: 38031028
Alzheimer's disease (AD) is a chronic illness marked by increasing cognitive decline and nervous system deterioration. At this time, there is no known medication that will stop the course of...
3.
Aslam Khan M, Stojanovic G, Bin Abdullah M, Dolatshahi-Pirouz A, Marei H, Ashammakhi N, et al.
Int J Biol Macromol . 2023 Nov; 254(Pt 3):127882. PMID: 37951446
Tissue engineering is an advanced and potential biomedical approach to treat patients suffering from lost or failed an organ or tissue to repair and regenerate damaged tissues that increase life...
4.
Marei H, Wang L, Cenciarelli C, Zhang W, Hua W
Front Oncol . 2023 Oct; 13:1288309. PMID: 37901320
No abstract available.
5.
6.
Mamun A, Ullah A, Chowdhury M, Marei H, Madappura A, Hassan M, et al.
Int J Biol Macromol . 2023 Aug; 250:126174. PMID: 37558025
Diabetic wounds are among the major healthcare challenges, consuming billions of dollars of resources and resulting in high numbers of morbidity and mortality every year. Lack of sufficient oxygen supply...
7.
Marei H, Hasan A, Pozzoli G, Cenciarelli C
Cancer Cell Int . 2023 Apr; 23(1):64. PMID: 37038154
Cancer is still the leading cause of death globally. The approval of the therapeutic use of monoclonal antibodies against immune checkpoint molecules, notably those that target the proteins PD-1 and...
8.
Marei H, Cenciarelli C
Biomedicines . 2023 Feb; 11(2). PMID: 36831164
Given that CAR-T cell therapy is effective in CD19-positive blood malignancies, it offers great hope for a variety of aggressive tumors that have thus far shown very little response to...
9.
Marei H, Yang C, Cenciarelli C, Jaillard A
Front Neurol . 2022 Dec; 13:1071557. PMID: 36468068
No abstract available.
10.
Cifola I, Fratini F, Cardinali B, Palmieri V, Gatti G, Selmi T, et al.
Biomedicines . 2022 Aug; 10(8). PMID: 36009432
Glioblastoma (GBM) is the most common and aggressive brain tumor in adults. Despite available therapeutic interventions, it is very difficult to treat, and a cure is not yet available. The...